Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmozyme in Refractory Acute Asthma
NCT00169962Phase 2Completed
- Sponsor
- Northwell Health
- Start
- Jan 2004
- Primary completion
- Sep 2006
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of dornase alfa in asthma (3 arms), sponsored by Northwell Health. Primary endpoint: Forced Expiratory Volume in 1 second. Started Jan 2004; status: completed.
02
Drugs
dornase alfa
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00169962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169962.